This online training session will cover a case study of the selection, installation and operation of a flexible design and production platform that allows for clinical vaccine production. This unique cGMP mobile adaptive biopharma production platform was placed into operation in New Haven, CT in April 2016. Installation occurred in a matter of days and has been certified and operational since early May 2016. This true, Facility of the Future solution enabled critical preclinical stage vaccine development and clinical trial manufacturing to occur in house, with ACT's technology and expertise. Dr. Donald S. Masters will discuss the rationale for selecting their adaptive facility solution and the operation of this innovative facility. You will gain insight into how one company defined their facility needs, developed flexible design and production platform selection criteria and worked to implement an innovative approach to meet their critical R&D enablement needs.
CEUs are provided once you achieve an 80% passing grade and complete the evaluation.